MycoBiomDB – Record Details (MyCo_3348)

Biomarker Record Details

Database ID: MyCo_3348
DB IDMyCo_3348
TitleRole of neutrophils in IL-17-dependent immunity to mucosal candidiasis
Year2014
PMID24442441
Fungal Diseases involvedOropharyngeal candidiasis
Associated Medical ConditionNone
GenusCandida
Speciesalbicans
OrganismCandida albicans
Ethical StatementProtocols were approved by the University of Pittsburgh Institutional Animal Care and Use Committee and adhered to guidelines in the Guide for the Care and Use of Laboratory Animals of the NIH.
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBiopsy
Sample sourceHomogenized Tongue tissue
Host GroupAnimal
Host Common nameMice
Host Scientific nameMus musculus
Biomarker NameIL-17
Biomarker Full NameInterleukin-17
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationPittsburgh, PA
CohortIL-23p19−/− mice were provided by Genentech (South San Francisco, CA) and IL 17RA−/− mice by Amgen (Seattle, WA) and bred in-house. All other mice were from The Jackson Laboratory (Bar Habor, ME) on the C57BL/6 background unless noted
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismOropharyngeal candidiasis (OPC, thrush) is an opportunistic mucosal infection caused by the commensal fungus Candida albicans. C. albicans causes disease when exposure is combined with host susceptibility through immunodeficiency or a breach in normal barriers. A range of primary and secondary immunodeficiency syndromes are associated with susceptibility to OPC, including the primary immunodeficiency Hyper-IgE syndrome and a family of genetic diseases leading to chronic mucocutaneous candidiasis (CMC). Secondary immunodeficiencies are now the most common predisposing factor for mucosal Candida disease. OPC is well described in patients with human immunodeficiency virus (HIV) and is considered an AIDS-defining illness. Cancer chemotherapy, immunosuppression for transplant recipients, renal failure and high-dose corticosteroids increase the risk of candidiasis.
TechniqueAnalytic
Analysis MethodFlow Cytometry Analysis
ELISA kitsNone
Assay DataNone
Validation Techniques usedFlow Cytometry Analysis, qRT-PCR
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone